192 related articles for article (PubMed ID: 19594068)
1. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].
Kostić G; Jovancić D; Saranac L; Bjelaković B
Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068
[TBL] [Abstract][Full Text] [Related]
2. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
Sandoval C; Kutscher M; Jayabose S; Tenner M
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
[TBL] [Abstract][Full Text] [Related]
4. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia.
Yap SM; MacEneaney P; Ryan C; O'Toole O
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113788
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
6. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
[TBL] [Abstract][Full Text] [Related]
7. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
[TBL] [Abstract][Full Text] [Related]
8. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.
Rollins N; Winick N; Bash R; Booth T
AJNR Am J Neuroradiol; 2004; 25(10):1688-95. PubMed ID: 15569732
[TBL] [Abstract][Full Text] [Related]
9. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
[TBL] [Abstract][Full Text] [Related]
10. Subacute methotrexate neurotoxicity in patients with oncohematological disease. A report of 3 cases.
Delgado EF; Ruggeri RA; Calvo C
Arch Argent Pediatr; 2023 Apr; 121(2):e202202649. PubMed ID: 36378235
[TBL] [Abstract][Full Text] [Related]
11. Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
Maeda M; Hayakawa J; Ueda T; Migita M; Asano T; Fukunaga Y; Amano Y
J Nippon Med Sch; 2005 Oct; 72(5):252-3. PubMed ID: 16247223
[TBL] [Abstract][Full Text] [Related]
12. [Methotrexate-induced stroke-like syndrome: A pediatric case report].
Marin F; Astorquizaga L; Font D; Palmieri F; Cheistwer A
Arch Argent Pediatr; 2021 Oct; 119(5):e550-e553. PubMed ID: 34569761
[TBL] [Abstract][Full Text] [Related]
13. A woman who couldn't speak: report of methotrexate neurotoxicity.
Szawarski P; Chapman CS
Postgrad Med J; 2005 Mar; 81(953):194-5. PubMed ID: 15749798
[TBL] [Abstract][Full Text] [Related]
14. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
16. Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL.
Dabagh S; David H; Young S; Doan A; Bhojwani D
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e839-e844. PubMed ID: 31876782
[TBL] [Abstract][Full Text] [Related]
17. [Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
Deneux V; Leboucq N; Saumet L; Haouy S; Akbaraly T; Sirvent N
Arch Pediatr; 2017 Dec; 24(12):1244-1248. PubMed ID: 29146215
[TBL] [Abstract][Full Text] [Related]
18. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H
Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity more likely in Hispanic children treated for acute lymphoblastic leukemia.
Printz C
Cancer; 2019 Feb; 125(4):494-495. PubMed ID: 30698835
[No Abstract] [Full Text] [Related]
20. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
